32 related articles for article (PubMed ID: 22444504)
1. Identification of post-mortem product of zolpidem degradation by hemoglobin via the Fenton reaction.
Yamagishi Y; Nagasawa S; Iwase H; Ogra Y
J Toxicol Sci; 2024; 49(6):261-268. PubMed ID: 38825485
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data.
Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL
Med J Aust; 2023 Jul; 219(2):63-69. PubMed ID: 37230472
[TBL] [Abstract][Full Text] [Related]
3. Drug Safety and Suicidality Risk of Chronic Pain Medications.
Syed O; Jancic P; Fink AB; Knezevic NN
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895968
[TBL] [Abstract][Full Text] [Related]
4. Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.
Fusaroli M; Pelletti G; Giunchi V; Pugliese C; Bartolucci M; Necibi EN; Raschi E; De Ponti F; Pelotti S; Poluzzi E
Drug Saf; 2023 Mar; 46(3):283-295. PubMed ID: 36689131
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study.
Sung HG; Li J; Nam JH; Won DY; Choi B; Shin JY
Soc Psychiatry Psychiatr Epidemiol; 2019 Dec; 54(12):1535-1544. PubMed ID: 31037540
[TBL] [Abstract][Full Text] [Related]
6. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.
McCall WV; Benca RM; Rosenquist PB; Riley MA; McCloud L; Newman JC; Case D; Rumble M; Krystal AD
Am J Psychiatry; 2017 Jan; 174(1):18-25. PubMed ID: 27609243
[TBL] [Abstract][Full Text] [Related]
7. The clinical and forensic toxicology of Z-drugs.
Gunja N
J Med Toxicol; 2013 Jun; 9(2):155-62. PubMed ID: 23404347
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological evidence for a low abuse potential of zolpidem.
Soyka M; Bottlender R; Möller HJ
Pharmacopsychiatry; 2000 Jul; 33(4):138-41. PubMed ID: 10958262
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system side effects associated with zolpidem treatment.
Toner LC; Tsambiras BM; Catalano G; Catalano MC; Cooper DS
Clin Neuropharmacol; 2000; 23(1):54-8. PubMed ID: 10682233
[TBL] [Abstract][Full Text] [Related]
10. Toxicology and characteristics of deaths involving zolpidem in New South Wales, Australia 2001-2010.
Darke S; Deady M; Duflou J
J Forensic Sci; 2012 Sep; 57(5):1259-62. PubMed ID: 22444504
[TBL] [Abstract][Full Text] [Related]
11. Contributory and incidental blood concentrations in deaths involving citalopram.
Darke S; Torok M; Duflou J
J Forensic Sci; 2013 Mar; 58(2):432-5. PubMed ID: 23278733
[TBL] [Abstract][Full Text] [Related]
12. Causes of community suicides among indigenous South Australians.
Austin AE; van den Heuvel C; Byard RW
J Forensic Leg Med; 2011 Oct; 18(7):299-301. PubMed ID: 21907931
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies.
Jones AW; Holmgren A
Forensic Sci Int; 2012 Oct; 222(1-3):118-23. PubMed ID: 22673707
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and circumstances of completed suicide by means other than overdose.
Darke S; Duflou J; Torok M
J Forensic Sci; 2009 Mar; 54(2):490-4. PubMed ID: 19220656
[TBL] [Abstract][Full Text] [Related]
15. Cocaine in sudden and unexpected death: a review of 49 post-mortem cases.
Pilgrim JL; Woodford N; Drummer OH
Forensic Sci Int; 2013 Apr; 227(1-3):52-9. PubMed ID: 22981213
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
